Item 12: Adoption of the report of the Commission on its sixty-seventh session CND Chair (Ghana): Excellencies, distinguished representatives, ladies and gentlemen. Good afternoon. We shall now turn our attention to item 12, adoption of the report of the Commission on its 67th session. We will proceed with the adoption of the draft resolutions. Before doing …
Informal Civil Society Dialogue with UNODC Executive Director 20 March 2024, 11am – 12 pm, Room: CR-3 Matej Kosir (Chair, VNGOC): Welcome. Question 1: Encouraged by CND resolution 65/4 of 2023 “Promoting comprehensive, evidence-based early prevention” and 2024 Global Initiative on Drug Use Prevention “the Declaration of Oviedo” signed by some 400 civil society organizations, …
Item 8. Inter-agency cooperation and coordination of efforts in addressing and countering the world drug problem Chair: Recalls documentation for the item. CND Secretariat: The meetings of the 5 subsidiary bodies were held last year in person and provided a great opportunity to meet and discuss good practices and areas of common concern. Following review …
9: Contributions by the Commission to the work of the Economic and Social Council, in line with General Assembly resolutions 75/290 A and 75/290 B, including follow-up to and review and implementation of the 2030 Agenda for Sustainable Development ECOSOC: An update on the contributions made by ECOSOC: during our coordination segment on Jan 31/Feb …
L3. Promoting rehabilitation and recovery management programmes as part of the comprehensive treatment of drug use disorders – sponsored by Chile Chair: Good Afternoon, we are tackling an L3 and L5 for an hour and half. Would like to start on a positive note, I was happy to see a consensus on scheduling in Plenary …
Chair: We will consider scheduling recommendations by WHO and INCB. CND Secretariat: Recalls the substances and scheduling recommendations. Chair: Explains process to schedule substances under 1961, 1971 and 1988 conventions. Butonitazene WHO: Butonitazene, or butoxynitazene, is a benzimidazole-derived synthetic opioid not currently under international control and lacking recognized therapeutic use. It appears as a crystalline …